BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26836920)

  • 1. Longitudinal Measurement of Pleural Fluid Biochemistry and Cytokines in Malignant Pleural Effusions.
    Thomas R; Cheah HM; Creaney J; Turlach BA; Lee YC
    Chest; 2016 Jun; 149(6):1494-500. PubMed ID: 26836920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor in pleural effusions and correlation with radiologic and biochemical parameters.
    Bayram N; Karakan Y; Uyar M; Ozyurt B; Filiz A
    Niger J Clin Pract; 2018 Jan; 21(1):59-62. PubMed ID: 29411725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant pleural fluid from mesothelioma has potent biological activities.
    Cheah HM; Lansley SM; Varano Della Vergiliana JF; Tan AL; Thomas R; Leong SL; Creaney J; Lee YC
    Respirology; 2017 Jan; 22(1):192-199. PubMed ID: 27560254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of interleukine-6, transforming growth factor-beta 1 and vascular endothelial growth factor in malignant pleural effusions.
    Duysinx BC; Corhay JL; Hubin L; Nguyen D; Henket M; Louis R
    Respir Med; 2008 Dec; 102(12):1708-14. PubMed ID: 18760578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-β1 rise in pleural fluid after tunneled pleural catheter placement: pilot study.
    Shojaee S; Voelkel N; Farkas L; de Wit M; Lee HJ
    J Bronchology Interv Pulmonol; 2013 Oct; 20(4):304-8. PubMed ID: 24162112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience.
    Loveland P; Christie M; Hammerschlag G; Irving L; Steinfort D
    Intern Med J; 2018 Nov; 48(11):1318-1324. PubMed ID: 29869427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine/Chemokine/Growth Factor Levels in Malignant Pleural Effusion of Non-small Cell Lung Cancer.
    Hayama N; Hattori S; Takahashi G; Takahashi F; Takeuchi T; Tanaka J; Horio Y; Takiguchi H; Tomomatsu K; Kitahara A; Takihara T; Niimi K; Oguma T; Asano K
    Tokai J Exp Clin Med; 2020 Dec; 45(4):224-229. PubMed ID: 33300594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count).
    Verma A; Dagaonkar RS; Marshall D; Abisheganaden J; Light RW
    Can Respir J; 2016; 2016():7348239. PubMed ID: 28070157
    [No Abstract]   [Full Text] [Related]  

  • 9. Pleural fluid analysis in malignant mesothelioma. Prognostic implications.
    Gottehrer A; Taryle DA; Reed CE; Sahn SA
    Chest; 1991 Oct; 100(4):1003-6. PubMed ID: 1914546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating unilateral pleural effusions: the role of cytology.
    Arnold DT; De Fonseka D; Perry S; Morley A; Harvey JE; Medford A; Brett M; Maskell NA
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30262573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-β, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion.
    Saraya T; Ohkuma K; Watanabe T; Mikura S; Kobayashi F; Aso J; Nunokawa H; Honda K; Ogawa Y; Tamura M; Sada M; Oda M; Inoue M; Yokoyama T; Kurai D; Ishii H; Kimura H; Takizawa H
    Lung; 2018 Apr; 196(2):249-254. PubMed ID: 29353318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas.
    Sriram KB; Relan V; Clarke BE; Duhig EE; Windsor MN; Matar KS; Naidoo R; Passmore L; McCaul E; Courtney D; Yang IA; Bowman RV; Fong KM
    BMC Cancer; 2012 Sep; 12():428. PubMed ID: 23009708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleural fluid microbiota as a biomarker for malignancy and prognosis.
    Kwok B; Wu BG; Kocak IF; Sulaiman I; Schluger R; Li Y; Anwer R; Goparaju C; Ryan DJ; Sagatelian M; Dreier MS; Murthy V; Rafeq S; Michaud GC; Sterman DH; Bessich JL; Pass HI; Segal LN; Tsay JJ
    Sci Rep; 2023 Feb; 13(1):2229. PubMed ID: 36755121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of pleural fluid data in patients with malignant effusion.
    Bielsa S; Salud A; Martínez M; Esquerda A; Martín A; Rodríguez-Panadero F; Porcel JM
    Eur J Intern Med; 2008 Jul; 19(5):334-9. PubMed ID: 18549935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor in pleural fluid for differential diagnosis of benign and malignant origin and its clinical applications.
    Fiorelli A; Vicidomini G; Di Domenico M; Napolitano F; Messina G; Morgillo F; Ciardiello F; Santini M
    Interact Cardiovasc Thorac Surg; 2011 Mar; 12(3):420-4. PubMed ID: 21172937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.
    Scherpereel A; Grigoriu BD; Noppen M; Gey T; Chahine B; Baldacci S; Trauet J; Copin MC; Dessaint JP; Porte H; Labalette M
    BMC Cancer; 2013 Jul; 13():324. PubMed ID: 23816056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
    Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
    Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions.
    Lieser EA; Croghan GA; Nevala WK; Bradshaw MJ; Markovic SN; Mansfield AS
    Lung Cancer; 2013 Oct; 82(1):63-8. PubMed ID: 23948549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.
    Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I
    J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.
    Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC
    BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.